HighVista Strategies LLC

Position in TERN — Terns Pharmaceuticals, Inc.

CIK 1335325 BOSTON, MA

Position in TERN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$6,026,265

-$1,062,399 QoQ

Shares Held

114,307

-34.9% QoQ

Ownership

0.099%

of shares outstanding

% of Portfolio

1.68%

of 13F equity value

Holder Rank

#121

of 316 holders

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HighVista Strategies LLC holds $224,607,258 across 76 Biotechnology names. TERN ranks #7 (2.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	113,254	$12,610,832
2	PRAX	Praxis Precision Medicines, Inc.	26,323	$8,481,007
3	COGT	Cogent Biosciences, Inc.	197,051	$7,584,492
4	SYRE	Spyre Therapeutics, Inc.	146,264	$7,377,556
5	PCVX	Vaxcyte, Inc.	124,647	$7,243,237
6	RVMD	Revolution Medicines, Inc.	69,309	$6,740,300
7	TERN	Terns Pharmaceuticals, Inc. This page	114,307	$6,026,265
8	GPCR	Structure Therapeutics Inc.	123,909	$5,972,413

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,026,265	114,307	-34.9%	Shares	Sole	2026-05-15
2025-12-31	$7,088,664	175,462	+34.0%	Shares	Sole	2026-02-17
2024-12-31	$725,551	130,966	0.0%	Shares	Sole	2025-02-14
2024-09-30	$1,092,256	130,966	-11.6%	Shares	Sole	2024-11-14
2024-06-30	$1,009,242	148,200	0.0%	Shares	Sole	2024-08-14
2024-03-31	$972,192	148,200	0.0%	Shares	Sole	2024-05-15
2023-12-31	$961,818	148,200	0.0%	Shares	Sole	2024-02-14
2023-09-30	$745,446	148,200	-17.5%	Shares	Sole	2023-11-14
2023-06-30	$1,572,112	179,670	+22.3%	Shares	Sole	2023-08-14
2023-03-31	$1,738,751	146,854	+89.9%	Shares	Sole	2023-05-15
2022-12-31	$787,361	77,344	0.0%	Shares	Sole	2023-02-14
2022-09-30	$455,556	77,344	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.